French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing
- PMID: 22350503
- DOI: 10.1007/s10689-012-9512-z
French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing
Abstract
To assess the impact of BRCA1/2 genetic test results on cancer-free women's breast-self-examination (BSE) practices and to prospectively determine their influence on psychological functioning. A prospective longitudinal study on French women's BSE practices and frequencies in BRCA1/2 carriers (N = 217) and non-carriers (N = 313) 1 and 2 years following disclosure of the test results, along with psychological factors predicting BSE practices. Before disclosure, BSE was practised by 47.2% of the women, and increased to 57.3% 1 year later. No change in the women's practices was noted between 12 and 24 months after the test. Carriers and non-carriers practicing regularly BSE at baseline were, respectively 8 to 6 times more likely to be practising BSE regularly at 12 months after being tested. Among the carriers, having fewer depressive symptoms at baseline and believing in the ability of BSE to detect breast cancer were found to be the most decisive factors associated with BSE practices 1 year after disclosure, following adjustment for BSE baseline practices. Among the non-carriers, believing in the ability of BSE to detect breast cancer, greater post-test anxiety, and a higher perceived risk of breast cancer were found to be predictors of post-test BSE practices after adjusting for BSE baseline practices. In France, where performing BSE is neither mandatory nor recommended, an increase in BSE practices was found to occur after disclosure of women's genetic test results, regardless of their carrier status.
Similar articles
-
Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends?Fam Cancer. 2013 Dec;12(4):601-10. doi: 10.1007/s10689-013-9621-3. Fam Cancer. 2013. PMID: 23475556
-
Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.Eur J Hum Genet. 2001 Jul;9(7):492-500. doi: 10.1038/sj.ejhg.5200668. Eur J Hum Genet. 2001. PMID: 11464240
-
Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?Psychooncology. 2014 Apr;23(4):420-7. doi: 10.1002/pon.3435. Epub 2013 Oct 11. Psychooncology. 2014. PMID: 24127257
-
[Breast cancer in BRCA1/2 mutation carriers].Cesk Patol. 2016 Fall;52(4):206-209. Cesk Patol. 2016. PMID: 27869445 Review. Czech.
-
French college of gynecologists and obstetricians (CNGOF) recommendations for clinical practice: Place of breast self-examination in screening strategies.Breast. 2024 Jun;75:103619. doi: 10.1016/j.breast.2023.103619. Epub 2024 Jan 3. Breast. 2024. PMID: 38547580 Free PMC article. Review.
Cited by
-
Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.BMJ Open. 2019 Sep 24;9(9):e029926. doi: 10.1136/bmjopen-2019-029926. BMJ Open. 2019. PMID: 31551380 Free PMC article.
-
What do women know about breast cancer prophylaxis and a healthy style of life?Rep Pract Oncol Radiother. 2015 Sep-Oct;20(5):321-7. doi: 10.1016/j.rpor.2015.06.001. Epub 2015 Jul 29. Rep Pract Oncol Radiother. 2015. PMID: 26549989 Free PMC article. Review.
-
Assessing Psychological Morbidity in Cancer-Unaffected BRCA1/2 Pathogenic Variant Carriers: A Systematic Review.Curr Oncol. 2023 Mar 25;30(4):3590-3608. doi: 10.3390/curroncol30040274. Curr Oncol. 2023. PMID: 37185387 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous